Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study
201780 citationsJournal Articlehybrid Open Access
Field-Weighted Citation Impact: 8.78
Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study | Researchclopedia